Diabetes Discourse: Recent Episodes
ReachMD
As the number of Americans living with diabetes continues to rise, staying up to date on the latest diabetes research is more essential than ever to help patients achieve glucose control. With Diabetes Discourse, you’ll hear from diabetes and endocrinology experts on emerging research, diagnostic and treatment strategies, and various elements that impact a patient’s disease course, including risk factors, vitamin and mineral supplementation, physical activity, and kidney disease. Because when it comes to diabetes, glucose control is just the beginning.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Ian de Boer, MD
Since up to 40 percent of patients with diabetes develop diabetic kidney disease, it’s essential to know how to proactively diagnose and treat them using the latest therapeutic advances and strategies. Tune in to hear Dr. Mary Katherine Cheeley discuss diabetes management in patients with chronic kidney disease with Dr. Ian de Boer, Professor of Medicine in the Division of Nephrology and the Director of the Kidney Research Institute at the University of Washington in Seattle.
Guest: Elena Toschi, MD
Approximately over the last decade, lifespans in the general population have increased, along with a rise in the prevalence of type 1 diabetes in older adult patients. Since each patient has a unique disease, the clinician should personalize and devise the best approach to diabetes management and glycemic targets, as well as manage comorbidities and complications. To learn more, join Dr. Elena Toschi, Director of the Young Adult Program at Joslin Diabetes Center and Assistant Professor of Medicine at Harvard Medical School.
Host: John Buse, MD, PhD
Guest: Kim Boggess, MD
The most common forms of diabetes encountered in pregnant patients include gestational diabetes and preexisting type 2 diabetes. So how does adding metformin to insulin treatment help these patients? Join Dr. John Buse as he talks about the MOMPOD Trial with lead author, Dr. Kim Boggess, Professor of Maternal Fetal Medicine at the University of North Carolina at Chapel Hill.
Guest: R. Paul Wadwa, M.D.
Since young kids have a different activity level and diet than older kids or adult patients, controlling type 1 diabetes in younger patients can be more challenging, and there tends to be more variability in their blood sugars. However, a recent study identified that hybrid closed-loop technology could help give children with type 1 diabetes the best outcomes and quality of life. To learn more, tune in with Dr. Paul Wadwa, Professor of Pediatrics and the Medical Director of the Pediatric Clinic at the Barbara Davis Center for Diabetes at University of Colorado Anschutz Medical Campus.
Host: Carol Wysham, MD
Guest: A. Michael Lincoff, MD
Given the growing evidence that obesity is associated with increased cardiovascular risk, a recent study assessed the impact of semaglutide on cardiovascular outcomes in patients who are overweight or obese but do not have diabetes. Not only did semaglutide reduce the risk of cardiovascular death, myocardial infarction, and stroke by 20 percent, but it also significantly reduced the risk of developing diabetes. Dive further into the findings and implications with Dr. Carol Wysham and study author Dr. Michael Lincoff.
Host: John Buse, MD, PhD
Guest: Louis J. Aronne, MD, FTOS
In the SURMOUNT-4 trial, 100 patients with obesity were on tirezpatide for 9 months, and the average weight loss was 20.9 percent. The patients were then randomized to receive either placebo with behavioral intervention or tirzepatide for another year, and the patients in the former group regained a significant amount of weight. Dive further into the study’s findings and implications with Dr. John Buse and Dr. Louis Aronne, the Sanford I. Weill Professor of Metabolic Research at Weill Cornell Medical College in New York.
Host: John Buse, MD, PhD
Guest: Mary de Groot, PhD
The prevalence of diabetes-related stigma is alarmingly high. In fact, four in five adults have reported experiencing some form of diabetes stigma at some point in their lives. To learn how we as healthcare providers can help reduce this burden for our patients with diabetes, Dr. John Buse speaks with Dr. Mary de Groot, Professor of Medicine and the Associate Vice Chair for Wellness at Indiana University School of Medicine.
Host: Stuart Weinzimer, MD
The artificial pancreas represents the integration of two separate devices: a continuous glucose monitor and an insulin pump. Learn more about this technology and how it can help improve diabetic patients’ quality of life with Dr. Stuart Weinzimer, Interim Section Chief of Pediatric Endocrinology and Diabetes at Yale School of Medicine.
Host: Stuart Weinzimer, MD
From continuous glocuose monitors to insulin pumps, there have been immense technological advancements for patients with type 1 diabetes. Learn more about how these two tools can be used to treat pediatric patients with type 1 diabetes with Dr. Stuart Weinzimer, Interim Section Chief of Pediatric Endocrinology and Diabetes at Yale School of Medicine.
Host: John Buse, MD, PhD
Guest: Michael Fang, PhD
According to a recent study published in the Annals of Internal Medicine, the median age of patients with type 1 diabetes is 24. However, type 1 diabetes that develops in adulthood is often mistakenly identified as type 2 diabetes, resulting in improper treatment. Joining Dr. John Buse to review this study’s key findings and how we can determine if an adult with new-onset diabetes might have type 1 diabetes is Dr. Michael Fang, Assistant Professor in the Division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University.
Host: John Buse, MD, PhD
Guest: Maria Jose Redondo, MD, PhD, MPH
A recent paper focused on a variety of topics associated with type 1 diabetes, including its heterogenenity, endotypes, slowly progressive insulin-dependent diabetes, and the term type 1.5 diabetes. Dive into these topics with Dr. John Buse and Dr. Maria Redondo, Professor of Pediatrics in the Division of Pediatric Diabetes and Endocrinology at Baylor College of Medicine in Texas.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: David Selzer, MD
New research suggests that a GLP-1 receptor agonist medication, semaglutide, which has been approved for type 2 diabetes and obesity, could also be used to treat type 1 diabetes in patients. So what are the risks for patients who have type 1 diabetes and who are obese? Joining Dr. Mary Katherine Cheeley to discuss this is Dr. David Selzer, Clinical Instructor of Medicine at NYU Grossman School of Medicine and leads the Medical Weight Loss Program at NYU Langone Medical Associates in the Florida Division.
Host: John Buse, MD, PhD
Guest: Helen Murphy, PhD
There are many challenges associated with managing type 1 diabetes (T1D) in pregnant patients, which is why a recent study examined the use of an automated insulin delivery system in this patient population. Using this method, insulin doses were adjusted every 8 to 10 minutes according to a patient’s real-time glucose levels taken from her continuous glucose monitor. As a result, women experienced a higher percentage time in the pregnancy glucose target range, less hyperglycemia, and less gestational weight gain. Learn more about how these findings may impact the management of T1D both during and after pregnancy with Dr. John Buse and Dr. Helen Murphy, a Professor of Medicine in Diabetes and Antenatal Care at the University of East Anglia in the United Kingdom.
Host: John Buse, MD, PhD
Guest: Beth Pyatak, PhD, OTR/L
According to a recent study, fluncuations in glucose levels while sleeping can directly impact type 1 diabetes patients’ ability to complete daily activities. In fact, it was found that higher variability overnight led to lower sustained attention and lower engagement in demanding activities the following day. So how can we control glucose levels to help our patients feel better? Explore the study’s key findings and management strategies with Dr. John Buse and Dr. Elizabeth Pyatak, an Associate Professor of Occupational Science and Occupational Therapy at the University of Southern California who worked on the study.
Host: John Buse, MD, PhD
Guest: Simon Heller, MD
Amid the crisis around the cost of diabetes care worldwide, biosimilar insulins could help save millions of dollars and allow more patients to be treated safely and effectively. But how exactly are these products approved, and how do they compare to the original product? Find out with Dr. John Buse and Dr. Simon Heller, Professor of Clinical Diabetes at the University of Sheffield and the Director of Research and Development at Sheffield Teaching Hospitals Foundation Trust in the United Kingdom. Together, they’ll review Dr. Heller’s recent paper on biosimilar basal insulins that was published in Clinical Diabetes.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Elizabeth Cook, PharmD, AE-C, BCACP, CDCES
With a shortage of insulin products in the United States, our diabetic patients are left without lifesaving medications, making this a prominent barrier in clinical practice. However, insulin biosimilars may offer more accessibility and affordability, but what do we know about them? Join Dr. Mary Katherine Cheeley as she speaks with Dr. Lizzie Cook, Clinical Pharmacist at Robert J. Dole Veteran Affairs Medical Center in Wichita, Kansas.
Host: John Buse, MD, PhD
Guest: Jean-Philippe Drouin-Chartier, DtP, PhD
What’s the relationship between ultra-processed food consumption and the risk of developing type 2 diabetes? Find out with Dr. John Buse as he speaks with Dr. Jean-Philippe Drouin-Chartier about his research that sought to answer this exact question. Dr. Drouin-Chartier is an Assistant Professor at the Faculté de Pharmacie at Laval University and a researcher in the Nutrition, Health, and Society Center of the Institute on Nutrition and Functional Foods in Quebec, Canada.
Host: John Buse, MD, PhD
Guest: David Cherney, MD, PhD
There have been several major advances regarding the management of chronic kidney disease in patients with type 2 diabetes over the last 5 years, leading Dr. David Cherney and a team of authors to publish a narrative review on how to best manage these patients using the latest treatment options like SGLT2 inhibitors and non-steroidal MRAs. Tune in to hear him share key highlights from the review with Dr. John Buse. Dr. Cherney is a Professor of Medicine at the University of Toronto and the Director of the Renal Physiology Laboratory at University Health Network in Canada.
Host: John Buse, MD, PhD
Guest: Louis Philipson, MD, PhD
Over the last 15 years, the monogenic diabetes registry now has over 4,000 patients involved, and from that, the RADIANT study was started to identify new kinds of rare and atypical diabetes. So how can genetics testing and the RADIANT study provide atypical diabetes patients with better diagnoses and treatment? Learn more with Dr. John Buse and Dr. Louis Philipson, Professor in the Department of Medicine and Pediatrics at the University of Chicago.
Host: John Buse, MD, PhD
Guest: David Simmons, MD
Gestational hypertension is more common in preeclampsia, and there’s more chance of the baby ending up in the neonatal intensive care unit. So what can we learn from the randomized trials of women patients with gestational diabetes? Learn more with Dr. John Buse as he speaks with Dr. David Simmons, Distinguished Professor of Medicine at the Western Sydney University Macarthur Clinical School in Australia.
Host: John Buse, MD, PhD
Guest: Karen D. Corbin, PhD, RD
One of the biggest missing links in current literature about obesity and the gut microbiome was causality. In an effort to address that gap, a recent clinical trial was conducted, and now, the results are in. So what were the key findings, and how can we translate those findings into clinical practice? Find out how one’s diet can affect the gut microbiome with Dr. John Buse and Dr. Karen Corbin, an Investigator at the AdventHealth Translational Research Institute in Orlando, Florida.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Suijit Janardhan, MD, PhD
Diabetic patients have a significant risk for developing more advanced liver disease, and the disease that they’re particularly at risk for is steatotic liver disease. Dive into this episode to learn more with Dr. Charles Turck and Dr. Sujit Janardhan, Assistant Professor in the Department of Internal Medicine, Division of Digestive Diseases and Nutrition, and the Department of Transplant Surgery at Rush University Medical Center in Chicago.
Host: John Buse, MD, PhD
Guest: Anna Kahkoska, MD, PhD
Continuous glucose monitoring (CGM) can help improve glycemic management in patients with type 1 diabetes (T1D), but integrating this technology can be a complex learning process for older adults. So what do we need to consider when it comes to CGM use in older adults? Find out with Dr. John Buse and Dr. Anna Kahkoska, Assistant Professor in the Department of Nutrition and an Adjunct Assistant Professor in the Division of Endocrinology and Metabolism at the University of North Carolina at Chapel Hill. Dr. Kahkoska is also the author of a recent paper, titled “Nothing is linear: Characterizing the determinants and dynamics of CGM use in older adults with type 1 diabetes.”
Host: John Buse, MD, PhD
Guest: Anastassios Pittas, MD, MS
Vitamin D has numerous benefits, and according to a recent study, it can even help reduce the risk of type 2 diabetes in patients with prediabtes. Learn more about the key findings from this research with Dr. John Buse and Dr. Anastassios Pittas, Professor of Medicine and Chief of Endocrinology at Tufts Medical Center.
Host: John Buse, MD, PhD
Guest: Viral Shah, MD
Severe hypoglycemia can lead to dangerous challenges, one of them being an increase in vehicular accidents. Dive into the results from a study that investigated the correlation between the prevalence of hypoglycemia while driving in adults with type 1 diabetes (T1D) and how many of those cases might have led to vehicular accidents with Dr. John Buse and Dr. Viral Shah, Associate Professor of Medicine and Pediatrics at the Barbara Davis Center for Diabetes.
Host: John Buse, MD, PhD
Guest: Steven Nissen, MD
Among statin-intolerant patients, treatment with bempedoic acid is associated with a lower risk of major adverse cardiovascular events according to a recent study. Dive into the study’s key findings with Dr. John Buse and Dr. Steven Nissen, who published the placebo-controlled study of bempedoic acid among statin-intolerant patients in The New England Journal.
Host: John Buse, MD, PhD
Guest: Elizabeth Selvin, PhD, MPH
As obesity rates continue to rise in adults with type 1 diabetes, what can we do to combat this growing obstacle? Dr. John Buse speaks with an expert in the field, Dr. Elizabeth Selvin, about obesity in patients with type 1 diabetes and shares management strategies.
Host: John Buse, MD, PhD
Guest: Ania Jastreboff, MD, PhD
Counseling patients with obesity who are on GLP-1 receptor agonists can be challenging. How can we leverage the biology of GLP-1 receptor antagonists to improve weight loss while avoiding side effects? Dr. John Buse speaks with a leading expert in the field, Dr. Ania Jastreboff, about the role of GLP-1 receptor agonists in weight loss.
Host: John Buse, MD, PhD
Guest: Jennifer B. Green, MD
The COORDINATE Study evaluated patients with cardiovascular disease and type 2 diabetes who encounter barriers in receiving newer diabetes medications. To better understand these gaps in care, Dr. John Buse speaks with one of the researchers, Dr. Jennifer Green from Duke University in Durham, North Carolina.
Host: John Buse, MD, PhD
Guest: Abbie E. Smith-Ryan, PhD, CSCS*D, FNSCA
There are immeasurable benefits to exercise, but the hard part for patients may be getting started. How can we help our patients make exercise a part of their lives? Dr. John Buse speaks with Dr. Abbie Smith-Ryan, a Professor of Exercise Physiology at the University of North Carolina – Chapel Hill, about the key benefits of exercise and how to encourage them for various patient populations.
Host: John Buse, MD, PhD
Guest: Sue Pedersen, MD, FRCPC
New guidelines published by Obesity Canada take a deep dive into pharmacotherapy and feature the latest recommendations on comorbidities and decision tools. To better understand the impact of these guidelines, Dr. John Buse speaks with one of the guidelines authors, Dr. Sue Pedersen, a specialist in endocrinology and metabolism.
Host: John Buse, MD, PhD
Guest: Silva Arslanian, MD
New research on once-daily semaglutide for adolescent patients with obesity may alter clinicians’ approach to care. What do we need to know? Dr. John Buse speaks with one of the study’s investigators, Dr. Silva Arslanian, from the University of Pittsburgh to dive into this clinical data and explore how these results may change the treatment landscape.
Host: John Buse, MD, PhD
Guest: Jennifer B. Green, MD
What does the latest research on glycemia reduction show us about the impact of glucose-lowering medication in combination with metformin on microvascular and cardiovascular outcomes in patients with type 2 diabetes? Dr. John Buse speaks with one of the study’s investigators, Dr. Jennifer Green, a Professor of Medicine at Duke University, about this emerging data.
Host: John Buse, MD, PhD
Guest: Deborah Wexler, MD
The GRADE study demonstrated the efficacy of different treatment options for patients with type 2 diabetes. To learn more about these treatment options, Dr. John Buse joins one of the study’s investigators, Dr. Deborah Wexler from Harvard Medical School and the Massachusetts General Hospital Diabetes Center, to dive into this study.
Host: John Buse, MD, PhD
Guest: Steven Russell, MD, PhD
Research continues to emerge on the bionic pancreas and its capabilities, and a recent study shows how it can count carbohydrates and lower A1c for patients with type 1 diabetes. To find out how it does, Dr. John Buse is joined by Dr. Steven Russell, an Associate Professor of Medicine at Harvard Medical School at the Massachusetts General Hospital.
Host: John Buse, MD, PhD
Guest: Martin de Bock, PhD FRACP
Recent research has explored the efficacy of open source automated insulin delivery devices for patient with type 1 diabetes. What did these results tell us? Dr. John Buse speaks with Dr. Martin de Bock, a pediatric endocrinologist at the University of Otago in Christchurch, New Zealand, to dive deeper into this research.
Host: John Buse, MD, PhD
Guest: Matthew Crowley, MD
Can telehealth change the way we manage persistently controlled type 2 diabetes (PPDM)? Dr. John Buse speaks with Dr. Matt Crowley, an Associate Professor of Medicine in the Department of Medicine in the Division of Endocrinology, Metabolism and Nutrition at Duke University, to explore some of the research on different methods of telehealth.
Host: John Buse, MD, PhD
Guest: Seth Berkowitz, MD, MPH
Food assistance programs like the Supplemental Nutrition Assistance Program (SNAP) can help relieve food insecurity. But can they also lower healthcare spending? To answer this question, Dr. John Buse sits down with Dr. Seth Berkowitz from the Division of General Medicine and Clinical Epidemiology at the University of North Carolina School of Medicine.
Host: John Buse, MD, PhD
Guest: Ashok Balasubramanyam, MD
Researchers from the GRADE study zeroed in on islet autoimmunity in beta cell dysfunction for patients with type 2 diabetes. What did various treatment options show us? Dr. John Buse speaks with Dr. Ashok Balasubramanyam, a Professor in the Department of Endocrinology, Diabetes and Metabolism at Baylor College of Medicine.
Host: John Buse, MD, PhD
Guest: Jose C. Florez, MD, PhD
Precision medicine may be the future of diabetes treatment. But what’s needed to implement this approach into practice? Here to explore this concept with Dr. John Buse is Dr. Jose Florez, Chief of the Endocrine Division and Diabetes Unit at the Massachusetts General Hospital.
Host: John Buse, MD, PhD
Guest: Carolyn Bramante
Emerging research has shed light on the possibility of generic drugs being repurposed for the treatment of COVID-19. Dr. John Buse discusses metformin, ivermectin, and fluvoxamine with Dr. Carolyn Bramante, an Assistant Professor in the Division of Geriatrics, Palliative and Primary Care at the University of Minnesota Medical School.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Javier Morales, MD, FACP, FACE
Out of the 32 million patients with diabetes in the United States, 40 percent also have chronic kidney disease. But what’s even more alarming is that only 10 percent of these patients know they have chronic kidney disease. So what strategies can we use to address the unmet needs and barriers faced when managing patients with chronic kidney disease and type 2 diabetes? Joining Dr. Charles Turck to answer this and other key questions is Dr. Javier Morales, Associate Clinical Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell on Long Island.
Guest: Gates B. Colbert, MD, FASN
Approximately 34 million patients live with diabetes in the United States, and up to 40 percent of those patients also have chronic kidney disease (CKD). That’s why it’s so important to know how to identify and prevent CKD progression in patients with diabetes, and here to share key strategies is Dr. Gates Colbert, Assistant Clinical Professor at Texas A&M College of Medicine.
Guest: Mikhail Kosiborod, MD
Patients with diabetes-related chronic kidney disease (CKD) are at high risk for a number of adverse events over a relatively short period of time. So what do we have in terms of efficacious therapies that can help make a positive impact in that regard? Here to share what we need to know about non-steroidal mineralocorticoid receptor antagonists (MRAs) for the treatment of diabetes-related CKD is Dr. Mikhail Kosiborod, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute.
Host: John Buse, MD, PhD
Guest: Ania Jastreboff, MD, PhD
In the ongoing battle against obesity, what does the SURMOUNT-1 study tell us about the role of tirzepatide? Dr. Ania Jastreboff, who is an Associate Professor of Medicine and the co-director of Weight Management and Obesity Prevention Program at Yale School of Medicine, chats with Dr. John Buse and this study’s findings.
Host: John Buse, MD, PhD
Guest: Rodica Pop-Busui, MD, PhD
The American Diabetes Association (ADA) published a new consensus report with the American College of Cardiology on heart failure in patients with diabetes. What does this report recommend—and how will these recommendations impact clinical practice? Dr. John Buse speaks with Dr. Rodica Pop-Busui from the University of Michigan about these updated heart failure recommendations.
Host: John Buse, MD, PhD
Guest: Kenneth Cusi, MD, FACP, FACE
The American Association of Clinical Endocrinology (AACE) released new recommendations for the diagnosis and management of NAFLD and NASH. To learn more about these updates, Dr. John Buse speaks with Dr. Kenneth Cusi, who is the Chief of the Division of Endocrinology, Diabetes and Metabolism in the Department of Medicine at the University of Florida.
Host: John Buse, MD, PhD
Guest: David Spence, MD
Pioglitazone was studied in the Insulin Resistance Intervention after Stroke trial, or IRIS for short. What do we need to know about it? Joining Dr. John Buse to share background and clinical data of the impacts observed is Dr. David Spence, a Professor Emeritus of Neurology and Clinical Pharmacology at Western University and the Director of the Stroke Prevention and Atherosclerosis Research Center in London, Ontario.
Host: John Buse, MD, PhD
Guest: Samuel Dagogo-Jack, MD, DSc
Intensive lifestyle interventions have shown to, if not prevent, significantly delay the onset of diabetes. But what do we need to know about these interventions? Joining Dr. John Buse to share clinical data and unravel the impacts of interventions in prediabetic patients is Dr. Samuel Dagogo-Jack from the University of Tennessee Health Sciences Center.
Host: John Buse, MD, PhD
Guest: Domenica M. Rubino, MD
The obesity epidemic affects millions of patients around the world, but a new treatment option may be a game-changer for the treatment landscape. Lead author of the STEP 8 clinical trial, Dr. Domenica Rubino, joins Dr. John Buse to share the insights from this drug trial and how these key clinical findings may impact the obesity treatment landscape.
Host: John Buse, MD, PhD
Guest: Anastasia-Stefania Alexopoulos, MBBS, MHS
Dr. John Buse joins Dr. Anastasia-Stefania Alexopoulos, an endocrinologist, researcher, and Assistant Professor of Medicine in the Department of Medicine at Duke University School of Medicine to share her research on the deintensification of hypoglycemia-inducing medications in diabetic adults.
Host: Carol Wysham, MD
Guest: Jane J. Kim, M.D.
Since 2020, pediatricians have seen a rapid rise in new-onset type 1 diabetes in children. Is this due to the COVID-19 pandemic or an indirect consequence of it? To answer this question, Dr. Jane Kim, a pediatric endocrinologist at Rady Children's Hospital in San Diego, shares what kind of correlation she's seeing.
Host: Carol Wysham, MD
Guest: Jane J. Kim, M.D.
Emerging research details a rapid rise in type 1 diabetes in children amid the COVID-19 pandemic. But what's causing this to happen? To dive into why, Dr. Carol Wysham is joined by Dr. Jane Kim from the Rady Children's Hospital in San Diego.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Eugene E. Wright, Jr., MD
Guest: Marina Basina, MD
What are some ways we can detect chronic kidney disease in patients with type 2 diabetes early? Joining Dr. Charles Turck to share collaborative strategies for early detection are Dr. Marina Basina from Stanford University Medical Center and Dr. Eugene Wright from the Charlotte Area Health Education Center.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Javier Morales, MD, FACP, FACE
There are several factors to consider when determining if insulin is the right treatment option for a patient with type 2 diabetes. And once a patient is prescribed insulin therapy, it’s just as important to consider the factors that might lead to nonadherence. That’s why Dr. Charles Turck speaks with Dr. Javier Morales about those factors and how we can improve our patients’ adherence to their insulin regimens.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Alexis McKee, MD
What communication strategies can we use to create personalized treatment plans and improve adherence among our patients with type 2 diabetes? That’s the exact question Dr. Charles Turck discusses with Dr. Alexis McKee, an Assistant Professor of Medicine in the Division of Endocrinology, Metabolism, and Lipid Research at the Washington University School of Medicine in St. Louis.
Host: Carol Wysham, MD
Guest: Rodica Pop-Busui, MD, PhD
Type 2 diabetes can be reflected in a patient's oral health, but can we say the same for patients with type 1 diabetes? Here to dive into that question and to share her latest findings in oral health in patients with type 1 diabetes is Dr. Rodica Pop-Busui, a Larry D. Soderquist Professor of Diabetes and Vice-chair for Clinical Research in the Department of Internal Medicine and also the Director of Clinical Research, Mentoring and Development of M-Diabetes at the University of Michigan.
Guest: Claresa Levetan, MD
How can we better communicate lifestyle changes and glucose monitoring levels with our diabetic patients? Dr. Claresa Levetan, an endocrinologist at Grand View Health in Lansdale, Pennsylvania, shares key communication strategies she uses with her patients.
Guest: Claresa Levetan, MD
Diabetes impacts around 40 million Americans and 25% of them don't even know they have it. Luckily, Diabetes Alert Day was created to spread awareness of this widespread disease. To help us understand this campaign, Dr. Claresa Levetan, an endocrinologist at Grand View Health in Lansdale, Pennsylvania, shares insights on the importance of Diabetes Alert Day.
Host: John E. Anderson, MD
Guest: Scott Pilla, MD, MHS
One of the most serious side effects of diabetes, hypoglycemia can lead to severe consequences, and keeping up with the latest in care can help us prevent this complication. To share the latest updates, Dr. John Anderson is joined by Lead Researcher Dr. Scott Pilla to share insights from his recent studies on hospital utilization and primary care communication for patients with diabetes.
Host: Carol Wysham, MD
Guest: Deepak Vashishth, PhD
Guest: Bowen Wang
Can we predict when a patient with COVID-19 requires hospitalization? To answer this question, Dr. Carol Wysham is joined by Dr. Deepak Vashishth and Mr. Bowen Wang from the Rensselaer Polytechnic Institute to share data from their study on the impact of glycemic levels and common medications on COVID-19 severity in patients with type 2 diabetes.
Host: John E. Anderson, MD
Guest: Elizabeth A. Beverly, PhD
Current treatment strategies for diabetic patients focus on behavioral and clinical targets alone, but can shared experiences and peer support improve care? To learn more about this, Dr. John Anderson talks to Dr. Elizabeth Beverly from the Ohio University Heritage College of Osteopathic Medicine to discuss her recent study on positive experiences for patients living with type 1 or type 2 diabetes.
Guest: George L. Bakris, MD
From diagnostic criteria to risk stratification, what do we need to know about recognizing early-stage diabetic kidney disease? Dr. George Bakris from the University of Chicago Medicine discusses detection strategies for diabetic kidney disease.
Host: Jennifer Caudle, DO
Guest: Jennifer B. Green, MD
What are some ways we can close the gaps in care for patients with diabetic kidney disease? Dr. Jennifer Caudle is joined by Dr. Jennifer Green from the Duke University School of Medicine to explore management challenges and share strategies to optimize care.
Host: Carol Wysham, MD
Guest: Christopher Taylor, PhD, RDN, LD, FAND
Dr. Carol Wysham meets with Dr. Christopher Taylor, Professor of Medical Dietetics at the Ohio State University School of Health and Rehabilitation Sciences, to take a look at low protein intake and its overall impact on diabetic patients.
Host: John E. Anderson, MD
Guest: Simon Heller, MD
Dr. Simon Heller, a Professor of Clinical Diabetes at the University of Sheffield, discusses glucose-lowering studies and talks about the link between hypoglycemia and thrombosis in patients with diabetes.
Host: John E. Anderson, MD
Guest: Simon Heller, MD
What causes sudden death in patients with type 1 diabetes? Dr. Simon Heller, a Professor of Clinical Diabetes at the University of Sheffield, discusses severe hypoglycemia and cardiovascular risk in patients with both type 1 and type 2 diabetes and what clinicians to look for.
Host: John E. Anderson, MD
Guest: Simon Heller, MD
Dr. Simon Heller, a Professor of Clinical Diabetes at the University of Sheffield, and honorary consultant physician with the NHS Foundation Trust in the United Kingdom, reflects on the steps we can take to prevent severe hypoglycemia and reduce cardiovascular risk in diabetic patients.
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
John Anderson joins fellow Diabetes Discourse hosts John Buse and Carol Wysham to explore exciting clinical trial results presented at this year's Scientific Session of the American Diabetes Association.
Host: John E. Anderson, MD
Guest: Michael Greenberg, MD
Dr. John Anderson joins Dr. Michael Greenberg, host of DermConsult, to discuss skin diseases that dermatologists should be aware of in patients with diabetes.
Host: Carol Wysham, MD
Guest: Kristen Nadeau, MD, MS
Is there a link between type 2 diabetes and obesity? Dr. Carol Wysham joins Dr. Kristen Nadeau, a Professor of Pediatric Endocrinology at the University of Colorado School of Medicine, to review her research on type 2 diabetes and what it could mean for our patients.
Guest: Carol Wysham, MD
ReachMD host Dr. Carol Wysham discusses what we currently know about hypoglycemia and cardiovascular disease, how to identify patients at risk for severe hypoglycemia, and the strategies and approaches to mitigate risk of hypoglycemia.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Deborah Hinnen, APN, BC-ADM, CDCES, FAAN
Ms. Deborah Hinnen, an advanced practice nurse and certified diabetes educator at the University of Colorado Health in Colorado Springs sits down with Dr. Charles Turck to discuss hypoglycemia risk factors and treatment protocols according to the ADA guidelines.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Alexis McKee, MD
Since patients with type 2 diabetes on multiple daily injections of insulin are at high risk of hypoglycemia, Dr. Charles Turck discusses essential counseling strategies for these high-risk patients with Dr. Alexis Mckee, an endocrinologist and Assistant Professor of Medicine at Washington School of Medicine in St. Louis, Missouri. Together, they’ll review how we can help patients avoid, manage, and treat hypoglycemia emergencies.
Guest: Jason M Ng, MD
Dr. Jason Ng, Clinical Lead of the Diabetes Technology Medical Home Unit at the University of Pittsburgh, shares strategies we can use to help patients with type 2 diabetes can lower their risk of hypoglycemia.
Guest: Rozalina G. McCoy, MD, MS
Tune in to hear primary care physician and endocrinologist Dr. Rozalina G. McCoy discuss how we can talk to our diabetes patients about hypoglycemia and what we need to consider when treating older patients who are experiencing hypoglycemia emergency.
Guest: Rozalina G. McCoy, MD, MS
Dr. Rozalina G. McCoy, an endocrinologist, primary care physician, and a National Institutes of Health-funded health services researcher examines hypoglycemia risk in insulin-treated type 2 diabetic patients and explores strategies to reduce their risk of recurrent hypoglycemia.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Brian M. Frier, MD
Dr. Charles Turck discusses the pervasiveness of hypoglycemia in adults with type 2 diabetes with Dr. Brian Frier, an Honorary Professor of Diabetes at the University of Edinburgh.
Host: John E. Anderson, MD
Guest: Raghu Mirmira, MD,PhD
When treating type 1 diabetes, should we be focusing on disease prevention rather than reversal? Dr. John Anderson takes a look at prevention tactics for type 1 diabetes progression with Dr. Raghu Mirmira, a Professor of Medicine and the Director of the Translational Research Center at the University of Chicago.
Host: Carol Wysham, MD
Guest: Irl Hirsch, MD, MACP
How is technology like continuous glucose monitors impacting the way we care for patients with diabetes, especially amid the COVID-19 pandemic? To learn more about the technological advancements in diabetes care, Dr. Carol Wysham speaks with Dr. Irl Hirsch, a Professor in Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine in Seattle, Washington.
Host: Carol Wysham, MD
Guest: Irl Hirsch, MD, MACP
Why was there so much discordance between some patients’ GMI and their measured A1C? That’s the exact question Dr. Irl Hirsch from the University of Washington School of Medicine asked and explored in a paper he recently co-authored. And now Dr. Hirsch is here to share his findings.
Host: John Buse, MD, PhD
Guest: Anne Louise Peters, MD
SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.
Host: John Buse, MD, PhD
It can be tempting for patients to undermine the seriousness of diabetes. But in recognition of Diabetes Alert Day, Dr. John Buse explains why we need to set the record straight.
Host: John Buse, MD, PhD
How early should we start screening for diabetes, and what tools are available to us? In recognition of Diabetes Alert Day, Dr. John Buse reviews the current screening tests and recommendations for those who are at risk of diabetes.
Host: John E. Anderson, MD
Guest: Matthias Hebrok, PhD
Emerging research may offer clinicians an alternative approach to treating type 1 diabetes. Dr. John Anderson meets with Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San Francisco, to discuss his groundbreaking research on insulin-producing stem cells.
Host: John E. Anderson, MD
Guest: Matthias Hebrok, PhD
What are the effects of type 1 diabetes on the body? Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San Francisco shares some insight on type 1 diabetes and its chronic impact on patients.
Host: John Buse, MD, PhD
Guest: Antonios Douros, MD
Dr. John Buse joins Dr. Antonios Douros, Assistant Professor in the Department of Medicine at McGill University and research investigator at Lady Davis Institute in Montreal, Quebec, to discuss his latest research focusing on SGLT2 inhibitors and diabetic ketoacidosis risk.
Host: Carol Wysham, MD
Guest: Alexis McKee, MD
Patient care has evolved amid the COVID-19 pandemic, causing unexpected challenges in managing diseases such as diabetes. Dr. Carol Wysham joins Dr. Alexis McKee, a practicing endocrinologist and an assistant professor of medicine at Washington School of Medicine in St. Louis, Missouri, to discuss how patients have been overcoming challenges in managing diabetes during the pandemic.
Host: John Buse, MD, PhD
Guest: David Wheeler, MB, CHB, MD, FRCP
Recent research has revealed that a type 2 diabetes treatment may help manage chronic kidney disease. Dr. John Buse discusses the use of dapagliflozin in patients with chronic kidney disease with Dr. David Wheeler, a professor of kidney medicine at the University College London in the United Kingdom, and an honorary consultant nephrologist at the Royal Free London NHS Foundation Trust.
Host: Carol Wysham, MD
Guest: Janet B. McGill, MD, MA, FACE, FACP
Many patients with diabetes don’t fit into our stereotypes of type 1 or type 2 diabetes and identifying them is key to understanding how to treat them. Dr. Carol Wysham discusses atypical diabetes with Dr. Janet McGill, a professor of medicine at the Washington School of Medicine in St. Louis, Missouri.
Host: John E. Anderson, MD
Guest: Jason Sloane, MD
There’s no denying that the COVID-19 pandemic has impacted every aspect of healthcare. So in an effort to recognize those who’ve gone above and beyond the call of duty, ReachMD’s Heroes in Healthcare initiative honors those healthcare professionals who were nominated by their peers for their outstanding contributions to the field of medicine. And one such nominee, Dr. Jason Sloane, joins Dr. John Anderson to discuss this nomination, strategies for optimal care, and his response to the COVID-19 pandemic.
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
Exercise is an essential part of maintaining a healthy lifestyle, especially when managing a chronic condition such as type 2 diabetes. But what should we take into consideration when prescribing it? Dr. John Anderson is joined by Dr. John Jackicic, Professor in the Department of Health and Physical Activity at the University of Pittsburgh, to discuss exercise prescriptions for patients with type 2 diabetes.
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
Physical activity is a valuable tool in treating patients with type 2 diabetes. But there are several factors clinicians must consider before prescribing exercise, including patient preference and limitations. Dr. John Anderson sits down with Dr. John Jackicic, Professor in the Department of Health and Physical Activity at the University of Pittsburgh, to discuss considerations when prescribing exercise to patients with type 2 diabetes.
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
Dietary decisions play a critical supporting role in the treatment of patients with type 2 diabetes. What kind of impact do these nutritional interventions have? Dr. Kathleen Stanley, a registered dietitian and certified diabetes educator with the Baptist Health Center joins Dr. John Anderson to discuss the impact of dietary recommendations on patients with type 2 diabetes.
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
Adhering to treatment can be challenging for many patients with diabetes. Especially for patients on bolus insulin, how can we encourage them to stick to treatment? Tune in to hear Diabetes Discourse hosts Drs. John Buse, Carol Wysham, and John Anderson discuss a patient case and strategies to overcome it.
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
Diabetic care looks different for every patient. And with so many different variables, challenging cases can become even more challenging to manage. What can endocrinologists do to overcome complicated cases? Dr. John Anderson is joined by his fellow Diabetes Discourse hosts, Dr. John Buse and Dr. Carol Wysham, to share their experiences with difficult cases and explore strategies to solve them.
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
The wintertime presents new challenges for patients with chronic diseases, specifically diabetes. But with the spread of COVID-19, how can we help keep our patients safe all winter long? Tune in to hear our Diabetes Discourse hosts Drs. Carol Wysham, John Buse, and John Anderson discuss strategies to effectively manage patients with diabetes during these winter months.
Published December X, 2020
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
The outbreak of the COVID-19 pandemic has pushed healthcare professionals to adjust the way they treat patients with chronic conditions like diabetes. Tune in to hear Drs. John Anderson, John Buse, Carol Wysham share their experience caring for patients with diabetes amid the pandemic.
Guest: Paresh Dandona, MD, PhD
Host: Farhad Zangeneh, MD
Host Dr. Farhad Zangeneh welcomes Paresh Dandona MD, PhD, Professor and Chief of Endocrinology in the Department of Medicine at the University of Buffalo. His Specialty and Research Focus are in Endocrinology, Diabetes and Metabolism. He is also the Founder & Medical Director of the Diabetes-Endocrinology Center of Western New York. In this program, Dr. Dandona will be discussing insulin induced cardioprotection, inflammatory and oxidative stress in acute myocardial infarction. He will also review hyperglycemia and cardiotoxicity in acute myocardial infarction. Please take a listen!
Guest: Robert A. Rizza, MD
Host: Farhad Zangeneh, MD
What are the sources of glucose in the body? Is diabetes a pancreatic disease or a hepatic disease? What is the importance of glucose toxicity in Type 1 or Type 2 diabetes patients? To answer these questions and many more, join our host Dr. Farhad Zangenh in a discussion with Dr. Robert Rizza, an authority in the regulation of carbohydrate metabolism in humans, and the Executive Dean for Research at Mayo Clinic. Download the podcast and listen in!
Host: Farhad Zangeneh, MD
Guest: Paul Jellinger
In diabetes management, clinicians typically measure glycemic control with fasting plasma glucose (FPG) and premeal glucose measurements, and HbA1c. And, the goals for each of these measurements have been established based on the results of many clinical trials. However, the majority of patients with diabetes fail to achieve these glycemic goals. Elevated postprandial glucose (PPG) concentrations may contribute to suboptimal glycemic control. Host Dr Farhad Zangeneh is joined by Dr. Paul Jellinger who will address the issue of postprandial glucose and its complications.
Paul S. Jellinger, MD and Master of the American College of Endocrinology (MACE) serves as Professor of Medicine on the voluntary faculty at the University of Miami and served as Chief of the Section of Endocrinology at Memorial Regional Hospital in Hollywood, Florida. Dr. Jellinger served as president of the AACE, the ACE and the Florida Endocrine Society. Dr. Jellinger has been active on the AACE Board of Directors.
Guest: Yehuda Handelsman, MD
Host: Farhad Zangeneh, MD
Dr Farhad Zangeneh is joined by Dr. Yehuda Handelsman, Medical Director at the Metabolic Institute of America; President of the American Association of Clinical Endocrinologists; and, Chair & Program Director, "Annual World Congress on Insulin Resistance, Diabetes & CVD".Dr. Handelsman will discuss the recent growing concerns between diabetes, anti-diabetes agents, and the increased prevalence of various cancers. Currently available data are limited, controversial, and confusing. The AACE and health care providers believe that this is a critically important area that needs further clarification.
Host: Farhad Zangeneh, MD
Guest: James R. Gavin, III, MD, PhD
Host Dr Farhad Zangeneh welcomes James R. Gavin III, MD, PhD, clinical professor of medicine at Emory University School of Medicine and at the Indiana University School of Medicine. Together they will explore the trends in the growth of diabetes in African Americans, the policies needed to address these problems, and some of the barriers that prevent better outcomes in diabetes care for African Americans and other high-risk minorities.
James R. Gavin III, MD AND PHD, clinical professor of medicine at Emory University School of Medicine and at the Indiana University School of Medicine. Dr. Gavin serves as CEO and Chief Medical Officer of Healing Our Village, Inc. He also belongs to a number of organizations, including the Institute of Medicine, the American Diabetes Association (ADA), the American Society of Clinical Investigation, the American Association of Physicians, and the Atlanta Rotary Club.
Guest: Kathleen "Kittie" Wyne, MD, PhD, FACE
Host: Farhad Zangeneh, MD
Host Dr. Farhad Zangeneh welcomes Dr. Kathleen "Kittie" Wyne from the The Methodist Hospital Research Institute (TMHRI) in Houston where she also coordinates their clinical research program in The Diabetes Research Center. Dr. Wyne discusses the changing classification of diabetes and pre-diabetes and how and when we should make the diagnosis. She also discusses the criteria for both diabetes and pre-diabetes and the tools available for clinicians.
Guest: George Grunberger, MD, FACP, FACE
Host: Farhad Zangeneh, MD
Host Dr. Farhad Zangeneh welcomes Dr. George Grunberger on a discussion on how to attain the best glucose control for our patients and how to do it safely. The discussion stems from altering lifestyle changes for our patients, addressing how to set individualized targets for our patients and identifying whats the best course of action.
Dr. George Grunberger, founder and chairman of the Grunberger Diabetes Institute in Bloomfield Hills, Michigan. He is Clinical Professor of Internal Medicine and Molecular Medicine & Genetics at Wayne State University School of Medicine in Detroit. Dr. Grunberger has published well over 100 original peer-reviewed manuscripts in addition to reviews and book chapters. His research spans subjects from molecular underpinning of insulin resistance to clinical studies on diabetes and its complications.
Guest: Aaron Kowalski, PhD
Host: Timothy Bailey, MD
The artificial pancreas project lead by the Juvenile Diabetes Research Foundation has made tremendous progress towards eventual outpatient clinical studies. A recent panel of experts met with the FDA and NIH to determine appropriate guidelines. What are regulatory guidelines for the artificial pancreas project? Join guest host Dr. Timothy Bailey and his guest, Assistant Vice President and Director of Glucose Control Research at the Juvenile Diabetes Research Foundation, Dr. Aaron Kowalski as they discuss developments from controlled inpatient settings to real-world conditions and the need for regulation.
Guest: Thomas Moore, MD
Host: Steven Edelman, MD
New screening standards for gestational diabetes could significantly increase the number of women and babies we identify as at-risk. Guest host Dr. Timothy Bailey talks with Dr. Thomas Moore, chairman of the department of reproductive medicine at the University of California, San Diego, about diabetes in pregnancy, and how gestational diabetes affects infant, childhood, and even adolescent obesity and overall health. They discusses screening methods for gestational diabetes, who is at risk, and the benefit from dietary interventions.
Host: Steven Edelman, MD
Guest: Sunder Mudaliar, MD
How can we prevent and treat pre-diabetes? Can a pill delay or prevent the onset of disease in high-risk individuals? Host Dr. Steven Edelman talks to Dr. Sunder Mudaliar, clinical professor of medicine in the division of endocrinology and metabolsim at the VA Medical Center and University of California San Diego School of Medicine, about the data on pioglitazone for diabetes prevention and the results of the ACT NOW study.
Guest: Lutz Heinemann, PhD
Host: Steven Edelman, MD
Biosimilar insulin is an attractive market to a number of American and European pharmaceutical companies. Biosimilar insulin manufacture is complicated for a number of reasons. Guest host Dr. Timothy Bailey talks with Dr. Lutz Heinemann, director of scientific services at Profil Institute for Clinical Research in San Diego and headquartered in Neuss, Germany, about the challenges and guidelines around producing safe and effective biosimilars. And, for healthcare providers, what are the practical aspects of switching to a biosimilar insulin?
Guest: Janis Roszler, CDE, RD, LD/N
Host: Steven Edelman, MD
About half of men with diabetes experience some kind of sexual dysfunction, and the numbers for women are not far behind. This week's guest, Janis Roszler, ceritified diabetes educator and marriage and family therapist, discusses the connection between sexual function and both physical and emotional well-being in patients living with diabetes. She makes the case for adding sexual function to the list of issues we talk about with patients who have diabetes. What are the causes of sexual dysfunction in these patients? Could drugs that help men also help women? Dr. Steven Edleman hosts.
Guest: Stephen Ponder, MD, CDE
Host: Steven Edelman, MD
A new study suggests newly trained physicians may not be adequately prepared to treat patients with diabetes. Host Dr. Steven Edelman, talks with Dr. Stephen Ponder, pediatric endocrinologist at Texas A&M, with 27 years of professional experience in the management of children with diabetes, about the implications for the next generation of patients and Dr. Ponder's recommendations for a mentoring system to provide additional training to young physicians.
Guest: John Walsh, PA, CDE
Host: Steven Edelman, MD
Insulin pump practice studies reveal new approaches in the management of diabetes, including carb-counting, carb boluses, hypoglycemia and transdermal insulin drug delivery. What are actual pump practices that lead to improved control? Join host Dr. Steven Edelman and his guest, John Walsh, PA, and certified diabetes educator at Advanced Metabolic Care and Research in Escondido, California, as they discuss pump practices that lead to improved control.
Guest: Jane Seley, DNP, MPH
Host: Steven Edelman, MD
The transition from hospital to home for patients with diabetes can be challenging, from glycemic targets, guidelines for initiating insulin therapy, the various types of insulin and oral agents to general nutrition. What are the current recommendations for the transition from hospital to home for patients living with diabetes? Join host Dr. Steven Edelman and his guest, Dr. Jane Jeffrie Seley, diabetes nurse practitioner and certified diabetes educator at New York-Presbyterian Hospital Weill Cornell Medical Center, as they discuss the differences in the current AACE and ADA inpatient and outpatient recommendations.
Guest: Linda Siminerio, RN, PhD, CDE
Host: Steven Edelman, MD
Insulin therapy can be challenging for both the patient with diabetes and their healthcare provider— from needle phobia to weight gain. How can healthcare providers shorten the learning curve to understanding insulin and its benefits? Join host Dr. Steven Edelman and his guest, Dr. Linda Siminerio, associate professor at the University of Pittsburgh School of Medicine, as they discuss insulin fact and fallacy for patients and providers.
Guest: David Henderson, MD
Host: Steven Edelman, MD
Antipsychotic medications have dramatically increased in prescriptions, including additional FDA-approved usages for bipolar and depression as well as off-label use. Side effects of these drugs, such as abdominal weight gain, lipid and blood pressure changes, and elevations in fasting glucose, may contribute to metabolic syndrome. What are the impacts of increased use of antipsychotic medications on diabetes? Join host Dr. Steven Edelman and his guest, associate professor of psychiatry at Harvard Medical School, Dr. David Henderson, as they discuss the need for healthcare providers to be proactive: understanding the patient's risk factors, medical history and the risk-benefit ratio in order to treat effectively.
Guest: Jeffrey La Belle, PhD
Host: Steven Edelman, MD
Many patients do not test blood glucose levels as often as they should, due to pain associated with the finger stick, as well as the need for an excess of testing paraphernalia. This week's guest discusses a potential non-invasive test on the horizon that would use tears to measure glucose levels. Dr. Jeffrey La Belle, biomedical engineering research professor in the School of Biological and Health Systems Engineering in Arizona State University's Ira A. Fulton Schools of Engineering and the Biodesign Institute, discusses promising new research in testing that may improve effectiveness and compliance with measuring blood glucose.
Guest: Eric Rackow, MD
Host: Steven Edelman, MD
The percentage of healthcare spending on chronic illnesses is increasing exponentially; critically for patients with diabetes. How can healthcare providers help their aging population to manage their diabetes and avoid costly hospital stays through home care management? Join host Dr. Steven Edelman and his guest, professor of medicine at the New York University School of Medicine, Dr. Eric Rackow, as they discuss new approaches for home care management strategies for patients living diabetes.
Guest: Natalie Strand, MD
Host: Steven Edelman, MD
The management of diabetes is an ongoing challenge for both the healthcare provider and patient in terms of balancing insulin regimens, glucose monitoring, diet and exercise. How does the diabetes educator help to "win the race" for a patient with diabetes? Join host Dr. Steven Edelman and his guest, interventional pain management physician and winner of the Amazing Race, Dr. Natalie Strand, as they discuss the integral role of the diabetes educator in the management of diabetes.
Guest: Simon Heller, MD
Host: Steven Edelman, MD
In 2004 the American Diabetes Association working group defined the threshold of hypoglycemia as 70 mg/dl. The clinical definition continues to attract controversy with a standard vs. dynamic solution. What are considerations that need to be made in terms of the clinical definition of hypoglycemia? Join host Dr. Steven Edelman and his guest, professor of clinical diabetes at the University of Sheffield, Dr. Simon Heller, as they discuss the challenge with the current threshold of hypoglycemia.
Guest: Patrick O'Connor, MD
Host: Steven Edelman, MD
A push away from the "one size fits all" approach to diabetes care, including subgroup analyses, patient preference, genetic factors and electronic records, is changing the way healthcare providers are caring for their patients. How do healthcare providers reflect these changes in their practices? Join host Dr. Steven Edelman and his guest, clinician of family medicine and senior investigator for HealthPartners, Dr. Patrick O'Connor, as they discuss a personalized approach to diabetes management.
Guest: Eric Topol, MD
Host: Timothy Bailey, MD
The challenges of treating diabetes include long-term monitoring and management, lifestyle change and adherence to medication. How are digital technology and genomics shaping the management of diabetes? Join guest host Dr. Timothy Bailey and his guest Dr. Eric Topol, director of the Scripps Translational Science Institute, as they discuss how digital technologies can improve glucose monitoring and genomics is leading to individualized treatment. Dr. Topol, who does not have diabetes, describes his personal experience living with continuous glucose monitoring for one week.
Disclosures Dr. Eric Topol has disclosed that he has received grants for clinical research from sanofi-avenitis. Dr. Topol has also disclosed that he has served as an advisor or consultant to sanofi-aventis and Daiichi Sankyo.
Guest: Elizabeth Kovacs, PhD
Host: Timothy Bailey, MD
Experimental approaches, including the suppression of certain immune cells to speed difficult wounds, may lead healthcare professionals to advances in the treatment of diabetic wounds. What are the therapeutic strategies and implications for our patients with diabetes? Join guest host Dr. Timothy Bailey and his guest, director of research at the Burn & Shock Trauma Institute at Loyola University Medical Center, Dr. Elizabeth Kovacs, as they discuss the latest research in suppressing certain immune cells to speed healing of slow-to-heal wounds.
Guest: Louis Aronne, MD
Host: Steven Edelman, MD
Treatment regimens for diabetes and obesity are merging. Healthcare professionals are taking a new view to the management of diabetes including rearranging diabetes medication regimens from a glucose control and weight-neutral perspective. What do healthcare professionals need to know to help their patients manage their diabetes? Join host Dr. Steven Edelman and his guest, clinical professor of medicine at Cornell Medical College, Dr. Louis Aronne, as they discuss considerations of drug therapies as weight neutral for treating their patients with type 2 diabetes.
Guest: Juan Pablo Frías, MD
Host: Steven Edelman, MD
Patients living with type 1 diabetes who are involved in athletics present particular challenges to approaching to their management, medication regimen and nutrition. How can healthcare professionals help their type 1 athletes optimize their performance and manage their diabetes? Join host Dr. Steven Edelman and his guest, director of research at TeamType1, Dr. Juan Frias, as they discuss restrictions, research, monitoring and adjusting insulin therapy for endurance type 1 athletes.
Guest: William Polonsky, PhD, CDE
Host: Timothy Bailey, MD
A majority of type 2 patients do not understand the benefits of structured self-monitoring of blood glucose and healthcare professionals lack the time to explain the values and the time to review the values themselves. What is the benefit of structured self-monitoring of blood glucose in patients with type 2 diabetes? Join guest host Dr. Timothy Bailey and his guest, founder of the Behavioral Diabetes Institute, Dr. William Polonsky, as they discuss the challenges and barriers for both healthcare professionals and patients with structured self-monitoring of blood glucose.
Guest: Candis Morello, PharmD, CDE
Host: Steven Edelman, MD
Medication adherence is one of the most challenging aspects of managing patients with diabetes. The majority of diabetes patients taking more than one oral agent do not adhere to their prescribed regimens. What is the key to successful adherence to drug regimens in patients living with diabetes? Join host Dr. Steven Edelman and his guest, associate professor of clinical pharmacy at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, Dr. Candis Morello, as they discuss results from a recent study on medication adherence for patients living with diabetes.
Host: Steven Edelman, MD
Guest: Azza El-Remessy, PhD, RPh
Retinopathy is one of the most common complications for patients living with diabetes but there are few treatment options and no early-stage interventions. How is research helping to pinpoint potential targets for early intervention and a possible oral treatment? Join host Dr. Steven Edelman and his guest, assistant professor and director of clinical and experimental therapeutics at the University of Georgia, Dr. Azza El-Remessy, as they discuss the latest research into the potential of statins to prevent diabetic-related blindness.
Guest: Jaime Davidson, MD
Host: Steven Edelman, MD
The relationship of insulin regimens to race and ethnicity is a new and growing area of research to better understand and provide clinical care at a personalized level. What are significant differences and approaches to these patients' diabetes management? Join host Dr. Steven Edelman and his guest, professor of internal medicine at the University of Texas Southwestern Medical School, Dr. Jaime Davidson, as they discuss the need for more clinical trials to better understand the differences of race and ethnicity on the efficacy and safety of commonly-used insulin regimens.
Guest: Tom Baranowski, PhD
Host: Steven Edelman, MD
How are video games showing promise as a behavior change strategy to improve children's diets? Newly-funded video-game programs are specifically designed to lower risk of type 2 diabetes and obesity in children. Join host Dr. Steven Edelman and his guest, professor of pediatrics at Baylor College, Dr. Tom Baranowski as they discuss innovative approaches to behavior change incorporating video games for children. Watch trailers for these games at www.archimage.com.
Guest: Linda Raynes Mahony, MS, RD, CDE
Host: Steven Edelman, MD
Fifty percent of patients living with diabetes will require some sort of renal replacement therapy. What percent will go on to renal transplantation and what are the recommendations for the management of these patients? Join host Dr. Steven Edelman and his guest, transplant dietitian at the University of California, San Diego, Linda Raynes Mahony, as they discuss medications, nutrition and overall management of renal transplant patients.
Guest: Matthew Riddle, MD
Host: Steven Edelman, MD
Patients on insulin therapy require personalized approaches to their mealtime intervention. What are the choices for patients who need something more to control glucose after meals? Join host Dr. Steven Edelman and his guest, professor of medicine at the Oregon Health & Science University, Dr. Matthew Riddle as they discuss meal time interventions for the treatment of type 2 diabetes.
Guest: Neal Kaufman, MD, MPH
Host: Steven Edelman, MD
Methods of positive behavioral change for people living with diabetes is vital to the overall management of diabetes. What is the value of behavior change for people living with diabetes and their professional counterparts? Join host Dr. Steven Edelman and his guest, professor of pediatrics and public health at the University of California, Los Angeles, Dr. Neal Kaufman, as they discuss the need for behavior modification in the treatment of type 2 diabetes.
Guest: Sheri Colberg-Ochs, PhD
Host: Steven Edelman, MD
Today's general exercise regimens for patients living with type 2 diabetes should emphasize a combination of both aerobic exercise and resistance training. What are the new guidelines concerning exercise and what do physicians needs to know when they prescribe exercise for their type 2 patients? Join host Dr. Steven Edelman and his guest, professor of exercise science at Old Dominion University, Dr. Sheri Colberg, as they discuss the American College of Sports Medicine/American Diabetes Association joint statement on exercise for type 2 diabetes.
Guest: Edward Damiano, PhD
Host: Steven Edelman, MD
Guest: Steven Russell, MD, PhD
The latest research into the use of glucagon and insulin in a closed-loop system is promising for the management of type 1 diabetes. How will the use of a bihormonal system benefit patients, and what is the path of treatment? Join host Dr. Steven Edelman and his guests, associate professor of biomedical engineering at Boston University, Dr. Edward Damiano, and instructor of medicine at Harvard Medical School, Dr. Steven Russell, as they discuss the challenges of a closed-loop system.
Guest: R. Keith Campbell, BPharm, MBA
Host: Steven Edelman, MD
Changes in both care and treatment of diabetes reflect trends in healthcare that may need revision. How can healthcare professionals benefit from new pharmacotherapies for their patients living with diabetes? Join host Dr. Steven Edelman and his guest, professor of pharmacy, Keith Campbell, as they discuss trends in healthcare that may require revisions for the care of people living with diabetes.
Guest: Sally Hara, MS, RD, CDE, CSSD
Host: Janice Baker, MBA, RD, CDE, CNSC
Exercise is essential for controlling blood sugar levels in patients with diabetes but benefits also present a set of unique challenges to athletes. What are the concerns medical professionals should be aware of and monitor for their athletes living with diabetes? Join guest host Janice Baker and Sally Hara, certified specialist in sports dietetics, as they discuss prescribing exercise regimens for the diabetic athletes.
Guest: Lois Jovanovic, MD, MACE
Host: Steven Edelman, MD
Universal guidelines in screening, diagnosis and early treatment for diabetes and pregnancy are presenting opportunities for the physician and patient to better manage their diabetes and the health of the newborn babies. What are the standards and what is the clinical relevance? Join host Dr. Steven Edelman and his guest, chief scientific officer of the Sansum Diabetes Research Institute, Dr. Lois Jovanovic, as they discuss the need to screen all pregnant women for diabetes.
Host: Janice Baker, MBA, RD, CDE, CNSC
Guest: Monika Woolsey
There are many challenges in overall diabetes management relative to a patients' mindful integration of food and behavior. What do healthcare professionals need to know to help their patients with diabetes better manage diet, stress and physical activity? Join guest host Janice Baker, CDE, RD and her guest, president and founder of "After The Diet" network, Monika Woolsey, RD, as they discuss the biochemistry and appetite regulation of diabetes and diet.
Guest: William Polonsky, PhD, CDE
Host: Janice Baker, MBA, RD, CDE, CNSC
Stress is an integral element in the management of diabetes. What are key questions healthcare professionals can ask of their patients dealing with diabetes-related stress? Join guest host Janice Baker, CDE, RD and her guest, founder of the Behavioral Diabetes Institute, Dr. William Polonsky, as they discuss the basics of stress and diabetes and we can better help our patients living with diabetes.
Guest: John Buse, MD, PhD
Host: Steven Edelman, MD
The recent American Diabetes Association / European Association for the Study of Diabetes consensus panel produced their treatment algorithm to control glycaemia in type 2 diabetes. How can healthcare professionals treating patients with type 2 diabetes provide additional prandial intervention to reach A1c targets? Join host Dr. Steven Edelman and his guest, professor of medicine at the University of North Carolina School of Medicine, Dr. John Buse, as they discuss the results of the glargine-exenatide combination study and its implications for a preferred treatment algorithm.
Guest: Jay Skyler, MD
Host: Steven Edelman, MD
Can immune intervention stop the disease process of type 1 diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine, pediatrics and psychology at the University of Miami, Dr. Jay Skyler, as they discuss the diagnosis, screening, testing and current immunotherapy research for the prevention and intervention of type 1 diabetes.
Guest: Vivian Fonseca, MD, FRCP
Host: Steven Edelman, MD
When should healthcare professionals treating patients with type 2 diabetes consider using insulin or incretin treatment or both? Join host Dr. Steven Edelman and his guest, president-elect of the American Diabetes Association and professor of medicine at Tulane University, Dr. Vivian Fonseca, as they discuss comparative and contrasting effects of both insulin and incretin treatment, the incretin effect and the clinical efficacy and safety of incretin-based therapies.
Guest: Alberto Hayek, MD
Host: Steven Edelman, MD
Diabetes research is the cornerstone for new opportunities in the treatment of patients living with diabetes. How will the newly formed Pediatric Diabetes Research Center serve this goal? Join guest host, certified diabetes educator Janice Baker and Dr. Alberto Hayek, professor of pediatrics and co-director of the UC San Diego's Pediatric Diabetes Research Center, as they discuss the need for collaboration in both biochemistry, molecular and cell-based therapies for the treatment of diabetes.
Guest: Amy Ozier, PhD, RD
Host: Steven Edelman, MD
The EADS (Eating and Appraisal Due to Emotions and Stress) questionnaire developed by Dr. Amy Ozier, registered dietitian and certified health education specialist, and assistant professor and facilitator of the Certificate of Graduate Study for Eating Disorders and Obesity at Northern Illinois University, helps healthcare professionals determine how psychological and physical factors modulate how much patients with diabetes eat. Does this tool help to bridge the gap when a psychologist is missing from a multi-disciplinary team? Dr. Ozier joins host Dr. Steven Edelman to discuss overeating as a contributing factor in a patient's overall health, the impact of hyperglycemia and treatment that helps modulate behavior.
Guest: Robert Henry, MD
Host: Steven Edelman, MD
The potential benefits of a new class of medications, sodium-dependent glucose cotransporter-2 therapy (or SGLT-2s), for type 2 diabetes is promising, but where will they fit in the treatment of diabetes and what are the risks? Join host Dr. Steven Edelman and his guest, professor of medicine at the Veterans Affairs Medical Center in San Diego, California, Dr. Robert Henry, as they discuss the mechanism, benefits and potential cardiovascular risks of this new class of medication.
Guest: Shereen Arent, JD
Host: Steven Edelman, MD
Healthcare reform will have significant implications for both patients living with diabetes and the healthcare professionals treating diabetic patients. How will healthcare reform impact current treatment, access and affordability? Join host Dr. Steven Edelman and his guest, executive vice president of government affairs & advocacy of the American Diabetes Association, Shereen Arent, as they discuss the impact of reform to cost of patient care, current and future prevention programs and the Affordable Care Act.
Guest: Craig Wargon, DPM
Host: Steven Edelman, MD
Patients with diabetes commonly need treatment for peripheral neuropathy. What are common symptoms and what should a physician be looking for in each patient visit? Join host Dr. Steven Edelman and his guest, practicing physician in the division of podiatric surgery at Kaiser Permanente, Dr. Craig Wargon, as they discuss symptoms, treatment and the need to glycaemic control in patients with diabetes.
Guest: Ann Albright, PhD, RD
Host: Steven Edelman, MD
The Centers for Disease Control and Prevention is aggressively becoming hands-on in the prevention of type 2 diabetes. A new national diabetes prevention program is under way under the tutelage of previous successful clinical research and trials results. What can healthcare professionals treating patients with diabetes learn and how can they get involved? Join host Dr. Steven Edelman and his guest, the director of the division of diabetes translation at the Centers for Disease Control and Prevention, Dr. Ann Albright, as they discuss the criteria for the National Diabetes Prevention Program.
Guest: Emmanuel Baetge, PhD
Host: Steven Edelman, MD
Current stem cell therapy research is leading the way into producing functional pancreatic, insulin-producing cells. How will this translate into clinical trials and human therapy for diabetes from a scale, delivery and efficacy position? Join host Dr. Steven Edelman and his guest Dr. Emmanuel Baetge, chief scientific officer of Viacyte, Inc., as they discuss the benefits of stem cell research therapy for diabetes.
Guest: Robert Cuddihy, MD
Host: Steven Edelman, MD
There have been impressive results with incretin-based therapy for patients with type 2 diabetes: improved A1C, beta-cell preservation and weight loss are some of the benefits. But do healthcare professionals need to temper their enthusiasm for this novel therapy? Join host Dr. Steven Edelman and his guest, medical director of the International Diabetes Center, Park Nicollet Health Services, Dr. Robert Cuddihy, as they discuss whether incretin-based therapy holds promise of a truly disease-modifying therapy.
Guest: Jennifer B. Green, MD
Host: Steven Edelman, MD
What is known about the relationship between glucose control and cardiovascular disease in diabetes? The recent Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial provides some interesting results on the relationship between type 2 diabetes and silent myocardial infarction. Join host Dr. Steven Edelman and his guest, assistant professor of medicine in the division of endocrinology, metabolism and nutrition at Duke University, Dr. Jennifer Green, as they discuss the role of glycemic control to cardiovascular disease in both sexes.
Guest: David Kendall, MD
Host: Steven Edelman, MD
The assessment of intensive glycemic control in preventing cardiovascular disease is unclear. Discrepancies in recent clinical trials such as ACCORD, ADVANCE, PROactive and UKPDS 80 may reflect difference in study design and patients, versus glycemic control. How can using the Archimedes model illuminate this quandary? Join host Dr. Steven Edelman and his guest, chief scientific and medical officer of the American Diabetes Association, Dr. David Kendall, as they discuss the effect of glycemic control on macrovascular outcomes in patients with diabetes.
Guest: Stanley Schwartz, MD
Host: Steven Edelman, MD
Guidelines that avoid the use of oral antidiabetes agents associated with hypoglycemia and weight gain are becoming increasingly popular in treating patients with diabetes. What are we learning about incretin-based therapies in both the intensive care and emergency medicine departments and perioperatively? Join host Dr. Steven Edelman and his guest, associate professor of medicine at the University of Pennsylvania, Dr. Stanley Schwartz, as they discuss the surprising results in both intensive care, emergency medicine and perioperative periods using incretin-based therapies.
Guest: Ralph A. DeFronzo, MD
Host: Steven Edelman, MD
New information on the state of impaired glucose tolerance indicates that the level of beta cell loss is greater than once considered. New treatment regimens are being considered to combat both the insulin sensitivity and beta cell loss for type 2 diabetes. What do health care professionals need to understand about the critical first steps in both the assessment and treatment of patients with type 2 diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine at the University of Texas Health Science Center, Dr. Ralph DeFronzo, as they discuss the potential of early combination and triple therapy to preserve beta cell function.
Guest: Fred Toffel, MD
Host: Steven Edelman, MD
Are the current ADA guidelines for inpatient care enough in the management of patients with diabetes? How are areas such as identification, assessment, glycemic control and nutrition therapy integrated? How are we approaching optimal glycemic control for inpatient care? Join host Dr. Steven Edelman and his guest, endocrinologist in Las Vegas, Nevada, Dr. Fred Toffel, as they discuss unique approaches to inpatient care for patients with diabetes.
Guest: Aaron Kowalski, PhD
Host: Steven Edelman, MD
The Artificial Pancreas Project under the auspices of the Juvenile Diabetes Research Foundation is making strides towards closing the loop with improvements in communication between glucose sensors and external insulin pumps. What progress has been made in closing the loop in the development of the artificial pancreas? Join host Dr. Steven Edelman and his guest, director of glucose control research at JDRF, Dr. Aaron Kowalski, as they discuss current systems and future development of the artificial pancreas.
Guest: Barbara Rolls, PhD
Host: Steven Edelman, MD
Current studies are reflecting the relationship between dietary energy density and energy intake in the management of the obese and patients with diabetes. How can physicians learn to integrate diet strategies for weight management in their patients with diabetes? Join host Dr. Steven Edelman and his guest, professor of nutritional sciences at Penn State University, Dr. Barbara Rolls as they discuss the benefits of diets low in energy density and "volumetrics."
Guest: Philip Zeitler, MD, PhD
Host: Steven Edelman, MD
The emergence of type 2 diabetes in both children and adolescents suggests a relationship between insulin sensitivity and puberty. What are we learning from recent studies and clinical research? Join host Dr. Steven Edelman and his guest, professor of pediatrics at the University of Colorado, Dr. Philip Zeitler as they discuss recent studies and clinical data that may shed light on this relationship.
Guest: Candis Morello, PharmD, CDE
Host: Steven Edelman, MD
The management of diabetes is a sophisticated multi-disciplinary approach. There are multiple benefits to both the physician treating diabetes patients and the patients themselves by increasing the role of the pharmacist to provide a collaborative approach to care and placing the patient at the center. Join host Dr. Steven Edelman and his guest, pharmacist from the Skaggs School of Pharmacy Sciences at the University of California, San Diego, Dr. Candis Morello, as they discuss the benefit of the increasing role of the pharmacist in the management of diabetes.
Host: Janice Baker, MBA, RD, CDE, CNSC
Guest: Lorena Drago, MS, RD, CDN, CDE
Whole grains have the potential to lower cholesterol as well as help manage blood glucose levels. What is the advantage of a whole grain diet in the management of diabetes? Join guest host registered dietitian Janice Baker and her guest, certified diabetes educator Lorena Drago, as they discuss the myths and facts of a whole grain diet in the management of diabetes.
Guest: Tim Garofolo, DDS
Host: Janice Baker, MBA, RD, CDE, CNSC
Periodontitis is considered the sixth major diabetes-related complication. What do healthcare professionals need to know to help their patients with diabetes? Join guest host and registered dietitian Janice Baker and her guest, dentist in San Diego, California, Dr. Timothy Garofolo, as they discuss symptoms, prevention and the management of diabetes-related periodontal disease.
Guest: Jim Flood
Host: Janice Baker, MBA, RD, CDE, CNSC
It is well established that exercise is a critical component in the management of diabetes, but many diabetes patients struggle with exercise. Physical therapists are the "exercise experts" in the guidance of patients' overall care. What are the benefits of physical therapy for patients living with diabetes? Join guest host, Janice Baker, RD, CDE, and her guest, physical therapist in San Diego, California, Jim Flood, as they discuss the benefits of designing an exercise plan for their patients.
Guest: Carlos Campos, MD, MPH
Host: Steven Edelman, MD
Healthcare professionals treating Hispanic patients with diabetes need to be rigorous in monitoring and treating this disease. Special considerations are required to address adherence issues and cultural norms. How can physicians learn to care and manage this growing population? Join host Dr. Steven Edelman and his guest, executive director for the Institute for Public Health & Education Research at the University of Texas Health Sciences, Dr. Carlos Campos, as they discuss the unique opportunities in managing and treating diabetes in the Hispanic population.
Guest: Angela Norton, RN, CDE, PHN
Host: Steven Edelman, MD
Diabetes educators focus on helping patients living with diabetes and related conditions achieve behavior change goals and lead to better clinical outcomes and improved health status. How has the role of the certified diabetes educator changed in the management of diabetes? Join host Dr. Steven Edelman and his guest, diabetes educator at SHARP Healthcare, Angela Norton, as they discuss the benefits and increasing role of the diabetes educator in the management of diabetes.
Guest: Francesco Rubino, MD
Host: Steven Edelman, MD
Gastrointestinal surgery for the morbid obese has long been an option in treatment, providing positive long-lasting results such as normal blood glucose and glycosylated hemoglobin levels and the discontinuation of diabetes-related medications. Is type 2 diabetes an operable intestinal disease? Join host Dr. Steven Edelman and his guest, chief of gastrointestinal metabolic surgery at Weill Cornell Medical College, Dr. Francesco Rubino, as they discuss the implications of metabolic surgery for type 2 patients.
Guest: Anne Louise Peters, MD
Host: Steven Edelman, MD
Initiating insulin therapy for type 2 patients provides its own set of challenges and opportunities. New insulin preparations and a better understanding of insulin physiology may provide physicians more options in effectively tailoring insulin therapy to the needs of their patients. Join host Dr. Steven Edelman and his guest, director of clinical diabetes programs at the University of Southern California, Dr. Anne Peters, as they discuss the benefits of initiating insulin therapy for type 2 patients.
Guest: Janice Baker, MBA, RD, CDE, CNSC
Host: Steven Edelman, MD
The prevalence of type 2 diabetes increases with age, with an estimated 8.6 million Americans over the age of 60 diagnosed with diabetes, and a growing number at-risk for developing diabetes with age. Our elderly face unique diabetes management challenges. Join host Dr. Steven Edelman and his guest, registered dietitian and Certified Diabetes Educator Janice Baker, as they discuss the unique challenges in caring for our elderly patients with diabetes.
Host: Steven Edelman, MD
Guest: Erminia (Mimi) Guarneri, MD, FACC, ABOIM
Integrative medicine appears to be an effective approach to the overall management of patients living with diabetes. Host Dr. Steven Edelman's guest, founder and medical director of the Scripps Center for Integrative Medicine in La Jolla, California, Dr. Mimi Guarneri, stresses that the more a patient puts in, the more they get out of an integrative medicine program. They discuss an integrative approach to risk modification and disease management focused on reducing stress, improving emotional state, increasing fitness, maximizing nutrition, and reducing dependence on medications.
Guest: Ken Fujioka, MD
Host: Steven Edelman, MD
Patients with type 2 diabetes struggle to lose or maintain weight, especially with particular therapies. What are some of the successful therapeutic interventions available for overweight patients with type 2 diabetes? What are the potential health effects of the loss of even 5 to 10 pounds for these patients? Join host Dr. Steven Edelman and his guest, director of the Nutrition and Metabolic Research Center and director of the center for Weight Management at the Scripps Clinic in La Jolla, California, Dr. Ken Fujioka, as they discuss the role that weight plays in the aetiology of diabetes and its particular benefits.
Guest: John (Jack) L. Leahy, MD
Host: Steven Edelman, MD
Where do thiazolidinediones, or TZD's, fit in our clinical approach to treating patients with type 2 diabetes? TZD's used early in the course of the disease seem to be a powerful therapy with a substantial reduction in the progression of type 2 diabetes. What does this tell us about the pathogenesis of diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine and chief of the division of endocrinology, diabetes and metabolism of the University of Vermont, Dr. Jack Leahy, as they discuss the pathogenesis of diabetes and the role of thiazolidinediones in the prevention and treatment of type 2 diabetes.
Guest: Francine Kaufman, MD
Host: Steven Edelman, MD
Diabetes has moved from being a disease of developed countries to a disease in developing countries such as India and Asia. What are some of the cultural influences surround this growing epidemic? Join host Dr. Steven Edelman and his guest, professor of medicine at the University of Southern California, Dr. Francine Kaufman, as they discuss the new challenges to this growing global epidemic.
Guest: Timothy Bailey, MD
Host: Steven Edelman, MD
Continuous glucose monitoring is an effective tool in the management of both type 1 diabetes and insulin-requiring type 2 diabetes patients. However, barriers and challenges remain for both the healthcare provider and patient. Join host Dr. Steven Edelman and his guest, director of the Advanced Metabolic Care + Research Institute, Dr. Timothy Bailey, as they discuss the benefits of and advances in continuous glucose monitoring.
Guest: Andrew Ahmann, MD
Host: Steven Edelman, MD
We now have many choices of oral agents in the treatment of type 2 diabetes patients. But choosing the type and where they fit in the treatment algorithm can be a challenge. Join host Dr. Steven Edelman and his guest, director of the Harold Schnitzer Diabetes Health Center, Dr. Andrew Ahmann, as they discuss the different classes of oral agents, benefits and treatment algorithms in the treatment of type 2 diabetes.
Guest: Janet Trowbridge
Host: Steven Edelman, MD
There are a number of skin conditions that affect people with diabetes: xerosis, acanthosis nigrican, necrobiosis lipoidica diabeticorum and more. What do healthcare providers need to know to diagnose and treat their patients? Join host Dr. Steven Edelman and his guest, dermatologist specializing in diabetes, Dr. Janet Trowbridge, as they discuss skin conditions in patients with diabetes.
Guest: Richard Arakaki, MD
Host: Steven Edelman, MD
Diabetes affects populations differently; diagnosis, treatment and prevention. Are there unique characteristics of Asian Americans with diabetes or pre-diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine at the University of Hawaii, Dr. Richard Arakaki as they discuss unique challenges and barriers for healthcare professionals managing diabetes in Asian American patients.
Guest: Wilfred Fujimoto, MD
Host: Steven Edelman, MD
The estimated prevalence and incidence of diabetes for Asian and Pacific-Islander youth is growing at an incremental rate. These populations present unique challenges in both diagnosis and treatment. Join host Dr. Steven Edelman and his guest, professor emeritus of internal medicine at the University of Washington, Dr. Wilfred Fujimoto as they discuss clinical characteristics, diagnosis, and unique challenges in the treatment of diabetes in this population.
Guest: Matthew Riddle, MD
Host: Steven Edelman, MD
Multiple choices of insulin therapy have provided a decided advantage to both the healthcare provider and patient living with diabetes. What are the specific benefits of customizing insulin therapy for our patients? Join host Dr. Steven Edelman and his guest, professor of medicine at Oregon Health & Science University, Dr. Matthew Riddle, as they discuss the benefits of standard versus individualized insulin therapy.
Guest: William Polonsky, PhD, CDE
Host: Steven Edelman, MD
Patients living with diabetes often struggle with motivation, depression and other emotional or behavioral challenges. How can healthcare professionals support their patients in the behavioral aspects of their diabetes care and the emotional challenges of their condition? Join host Dr. Steven Edelman and his guest, founder of the Behavioral Diabetes Institute, Dr. William Polonsky as they discuss the need for understanding and support, what's wrong with 'policing,' and good diabetes etiquette in the management diabetes.
Guest: Rachel Kim, MD
Host: Steven Edelman, MD
Diabetes may affect the musculoskeletal system in a variety of ways. The metabolic perturbations in diabetes result in changes in the connective tissue. What are current recommendations for healthcare providers as an overall strategy in the treatment of patients living with diabetes? Join host Dr. Steven Edelman and his guest, rheumatologist at the Scripps Clinic, Dr. Rachel Kim, as they discuss musculoskeletal complications, intervention and treatment.
Guest: Debra Simmons, MD
Host: Steven Edelman, MD
The ALLHAT hypertension study results indicated that less costly, traditional diuretics are more effective than newer medicines at lowering high blood pressure and preventing some forms of heart disease. Join host Dr. Steven Edelman and his guest, endocrinologist and director of the endocrinology, diabetes and metabolism training program at the University of Arkansas Medical Sciences and Central Arkansas Veterans Healthcare System, Dr. Debra Simmons as they the results and implications of the Antihypertensive Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) clinical study.
Guest: Matthias von Herrath, MD
Host: Steven Edelman, MD
Development of a combination therapy is showing significant promise in type 1 diabetes when caught in the early stages. What are some immuno-therapies currently being evaluated for treating type 1 diabetes? Join host Dr. Steven Edelman and his guest, director of the Center for Type 1 Diabetes Research at the La Jolla Institute for Allergy and Immunology, Dr. Matthias von Herrath, as they discuss histopathology, antigen-specific therapy, anti-CD3d antibodies and more.
Guest: Nancy Bohannon, MD
Host: Steven Edelman, MD
Will insulin pumps become the preferred therapy for patients with type 2 diabetes who are not at goal? New insulin pump technology and patch pumps are offering a whole new level of customization, an ability to improve glucose control and quality of life. Join host Dr. Steven Edelman and his guest, endocrinologist and director of clinical research at St. Luke’s Hospital, Dr. Nancy Bohannon as they discuss new insulin pump technology.
Host: Steven Edelman, MD
Guest: Irwin Goldstein, MD
The vascular, neurologic, hormonal and psychological issues associated with the diabetes and metabolic syndromes are commonly the cause of sexual problems. What benefit does a multidisciplinary approach to sexual medical issues bring to people living with diabetes? Join host Dr. Steven Edelman and his guest, director of San Diego Sexual Medicine at Alvarado Hospital in Southern California, Dr. Irwin Goldstein, as they discuss both male and female sexual dysfunction, treatments and a multidisciplinary approach to sexual medical issues.
Guest: David Marrero, PhD
Host: Steven Edelman, MD
Recent studies done with primary prevention were designed to prove that lifestyle changes could reduce the risk for diabetes in people at high risk of developing the disease. What can we learn from novel pilot programs in the prevention of type 2 diabetes? Join host Dr. Steven Edelman and Dr. David Marrero, director of the Diabetes Translational Research Center at the Indiana University School of Medicine, as they discuss translational research, specific results of the “Plan Forward” program and implications for clinical care.
Host: Steven Edelman, MD
Guest: Joe Piscatella
According to the National Institutes of Health, 85% of physicians state they are not effective in helping patients make healthy dietary changes. What are the obstacles for our healthcare professionals treating patients with diabetes? Join host Dr. Steven Edelman and his guest, best-selling author and national speaker, Joe Piscatella, as they discuss strategies and techniques for healthcare professionals in helping their patients institute and maintain a healthy diet.
Guest: Kriss Halpern, JD
Host: Steven Edelman, MD
The current state of coverage for people living with diabetes is stressed with approximately fifteen percent of all diagnosed diabetics with no health insurance, another group at risk of losing their health insurance and the last group paying exorbitant premiums to keep their insurance. How will reform affect healthcare professionals treating patients with diabetes? Join host Dr. Steven Edelman and his guest, attorney specializing in diabetes, Kriss Halpern, as they discuss the elements of proposed healthcare reform as it relates to treating patients with diabetes.
Guest: Stephen Ponder, MD, CDE
Host: Steven Edelman, MD
The emergence of type 2 diabetes in children and adolescents over the past 20 years represents a shift in pediatric chronic disease. Join host Dr. Steven Edelman and his guest, professor of pediatrics and director of the Children’s Diabetes and Endocrine Center of South Texas at Driscoll Children’s Hospital, Dr. Stephen Ponder, as they discuss key challenges in both diagnosis and medical management of this group.
Guest: Robert Henry, MD
Host: Steven Edelman, MD
The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results and implications for clinical care.
Guest: Bruce Buckingham, MD
Host: Steven Edelman, MD
The developing artificial pancreas carries tremendous potential for the treatment of diabetes. What is research telling us about the various steps to the implementation of the system? Join host Dr. Steven Edelman and his guest, pediatric endocrinologist and professor of medicine at Stanford University, Dr. Bruce Buckingham, as they discuss design, function, implementation, and obstacles to developing the artificial pancreas.
Guest: Richard Bergenstal, MD
Host: Steven Edelman, MD
The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.
Guest: Anne-Marie Felton
Host: Steven Edelman, MD
World Diabetes Day marks the annual global awareness campaign for diabetes by the International Diabetes Federation. The campaign’s theme of "diabetes education and prevention" is scheduled for five years. How will the IDF implement this broad campaign for both the health care professionals and people living with diabetes? Join host Dr. Steven Edelman and his guest, vice president of the International Diabetes Federation, Anne-Marie Felton, as they discuss World Diabetes Day and the need for diabetes education and prevention.
Guest: Joseph Ma, PharmD
Host: Steven Edelman, MD
Pharmacogenomics is applied to select medications with the goal of optimizing drug therapy: maximizing efficacy, minimizing toxicity, and minimizing pharmacokinetic and pharmacodynamic variability. Join guest host, Dr. Candis Morello and Dr. Joseph Ma, assistant professor of clinical pharmacy at the University of San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, as they discuss the impact of pharmacogenomics in diabetes therapy.
Guest: Lisa Kroon, PharmD, CD
Host: Steven Edelman, MD
The new class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which stimulate the pancreas to make more insulin after eating a meal, may be changing the way we treat people with type 2 diabetes. Join guest host, Dr. Candis Morello and her guest, professor of clinical pharmacy in the School of Pharmacy at the University of California San Francisco, Dr. Lisa Kroon, as they discuss the use of DPP-4 therapy in the treatment of type 2 diabetes.
Guest: Sandra Bourdette
Host: Steven Edelman, MD
The results of the landmark Diabetes Control and Complications Trial proved that intensive management of diabetes can significantly improve diabetes outcomes. The education of both the healthcare professional and patient is a key component in the successful management of diabetes. Join host Dr. Steven Edelman and his guest, executive director of Taking Control of Your Diabetes (TCOYD), Sandra Bourdette, as they discuss the mission and results of their novel approach to diabetes education.
Guest: Sarah Lorentz, PharmD
Host: Candis Morello, PharmD, CDE
Why are people living with diabetes more likely to die with flu and pneumonia? During flu epidemics, this risk is particularly high when additional risk factors present such as cardiovascular disease and kidney disease. Join guest host Dr. Candis Morello and her guest, pharmacist specializing in ambulatory care, Dr. Sarah Lorentz, as they discuss the reasons immunizations for patients with diabetes are so crucial.
Host: Candis Morello, PharmD, CDE
Guest: Brookie Best, PharmD
New drug delivery technologies are changing one of the key therapeutic challenges of insulin delivery in the management of diabetes. Join guest host Dr. Candis Morello and her guest, Dr. Brookie Best, assistant clinical professor of pharmacy and pediatrics at University of California San Diego, as they discuss the emerging new technologies being developed in this space.
Guest: Daniel Einhorn, MD
Host: Steven Edelman, MD
The new American Association of Clinical Endocrinologists (AACE) guidelines represent a major shift in the way type 2 diabetes is treated. An emphasis on hypoglycemia, adherence to therapy and new medications are included in this new algorithm. Join host Dr. Steven Edelman and his guest, president-elect of AACE, Dr. Daniel Einhorn, as they discuss the principles underlying the new guidelines and how they differ from other guidelines.
Guest: David Ward, MD
Host: Steven Edelman, MD
Diabetes is the most common cause of kidney failure. However, most people with diabetes can avoid end-stage kidney disease and minimize their risk of kidney failure with intensive management of diabetes. Join host Dr. Steven Edelman and his guest, nephrologist and professor of medicine at the University of California San Diego, Dr. David Ward as they discuss diagnosis, symptoms, prevention and treatment of diabetic kidney disease.
Guest: Irl Hirsch, MD, MACP
Host: Steven Edelman, MD
Lowering blood sugar levels in critically ill patients is a widely embraced practice. But according to the results of the NICE-SUGAR study, lowering blood glucose levels in ICU patients may not be safe. Join host Dr. Steven Edelman and his guest, Dr. Irl Hirsch, professor of medicine and the Diabetes Treatment and Teaching chair at the University of Washington in Seattle, as they discuss the results of the NICE-SUGAR study and its implications for treating critically ill patients.
Guest: Thomas Moore, MD
Host: Steven Edelman, MD
Characterized by high blood sugar levels first recognized during pregnancy, gestational diabetes affects about four percent of all pregnant women. Join host Dr. Steven Edelman and Dr. Thomas Moore, director of perinatal medicine at University of California, San Diego Medical Center, as they discuss the diagnosis and treatment for gestational diabetes.
Host: Steven Edelman, MD
Guest: Lorena Drago, MS, RD, CDN, CDE
According to a recent study, people with type 2 diabetes are not meeting important nutritional recommendations. Finding the correct balance of carbohydrates, protein and fat along with portion control and moderation is a challenge. Our guest, dietitian and certified diabetes educator, Lorena Drago, discusses the variance in recommended diets for people living with diabetes. Join host Dr. Steven Edelman to learn more.
Host: Steven Edelman, MD
Guest: Vivian Fonseca, MD, FRCP
SGLT2 is responsible for glucose re-absorption in the kidney and decreasing SGLT2 function promotes glucose excretion to help reduce blood sugar levels, making it an attractive area for the treatment of diabetes. Join host Dr. Steven Edelman and his guest, professor of medicine at Tulane University, Dr. Vivian Fonseca, as they discuss the new class of medications being investigated for the treatment of type-2 diabetes.
Guest: Ralph A. DeFronzo, MD
Host: Steven Edelman, MD
Insulin resistance in muscle, liver and ß-cell represent the core pathophysiologic defects in type 2 diabetes. In addition, the ominous octet all play important roles in the development of glucose intolerance in people with type 2 diabetes. How will this new paradigm shift our understanding in the way we treat our type 2 patients? Dr. Ralph DeFronzo, professor of medicine and author of the recent Banting Lecture, “From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus,” discusses new therapies based on the pathophysiology. Join host Dr. Steven Edelman to learn more.
Guest: John Buse, MD, PhD
Host: Steven Edelman, MD
Diabetes therapeutics such as glucose and weight control are major physiological functions of the new glucagon-like peptide-1 (GLP-1) agonists. But is there evidence to suggest that GLP-1 may also have some cardiovascular benefits? Join host Dr. Steven Edelman and Dr. John Buse, professor of medicine at the University of North Carolina at Chapel Hill School of Medicine, as they discuss the emerging cardiovascular actions of incretin hormones.
Guest: Kelly Close, MBA
Host: Steven Edelman, MD
The prevalence of diabetes complications and its associated costs represent an infrastructure that may be virtually unsustainable in the near future. Join host Dr. Steven Edelman and his guest, editor-in-chief of the diabetes publications Closer Look and Diabetes Close Up, Kelly Close, as they discuss the challenges of both regulation and reimbursement.
Guest: Robert Henry, MD
Host: Steven Edelman, MD
The physiological effects of glucagon-like peptide-1 (GLP-1) are exciting because of the potential clinical relevance in treating two of the major abnormalities that contribute to type 2 diabetes: impaired insulin secretion and excessive glucagon secretion. GLP-1 also appears to have effects on gastric emptying and appetite suppression. Join host Dr. Steven Edelman and his guest Dr. Robert Henry, professor of medicine at the University of California, San Diego, and chief of both the section of endocrinology, metabolism and diabetes and the Center for Metabolic Research at the VA Medical Center in San Diego.
Guest: Daniel Blanchard, MD
Host: Steven Edelman, MD
Diabetes is strongly linked with a number of risk factors for coronary problems such as high blood pressure, high cholesterol, abdominal obesity that significantly increases the risk of heart attack and stroke. Recent studies indicate that new drug-eluting stents are a reasonable option for the diabetic population who do not want bypass or that don’t present with severe disease involving all of their blood vessels. Join host Dr. Steven Edelman and his guest, chief of clinical cardiology and professor of medicine Dr. Daniel Blanchard, as they discuss the latest in screening and treatments for heart disease.
Guest: Patrick J. Boyle, MD
Host: Steven Edelman, MD
The frequency of hypoglycemic events for both type 1 and type 2 diabetics increases due to tight blood glucose control and more intensive treatment schedules. The disease differs significantly between type 1 and type 2 in the body’s defense mechanism of decreasing insulin concentration. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine Dr. Patrick Boyle, as they discuss what health care professionals need to know to help their patients avoid and treat hypoglycemia.
Guest: Ingrid Kruse, DPM
Host: Steven Edelman, MD
Diabetic peripheral neuropathy remains one of the most common complications in diabetes. Because type 2 diabetes often goes undiagnosed for many years, it is common for patients to present with some degree of neuropathy. Our guest, podiatrist, specializing in diabetic foot problems, Dr. Ingrid Kruse, discusses the variance in both symptoms and treatments for diabetic peripheral neuropathy. Join host Dr. Steven Edelman to learn more.
Host: Steven Edelman, MD
Guest: Candis Morello, PharmD, CDE
Dietary supplements and alternatives medicines are on the rise, however effectiveness of most of these products has not been demonstrated. Supplements differ significantly over prescription drugs in both production and regulation. How do healthcare professionals stay ahead of this rapidly growing area? Join host Dr. Steven Edelman and his guest, pharmacist and certified diabetes educator Dr. Candis Morello, as they discuss the need for further education and information. You can find out more about dietary supplements from the National Institutes of Health's Office of Dietary Supplements here, and from the NIH's National Center for Complementary and Alternative Medicine here.
Guest: Niren Angle, MD
Host: Steven Edelman, MD
People with diabetes are at increasingly higher risk for developing peripheral arterial disease. However, the disease may have no symptoms and often goes undiagnosed. What is the link between PAD and diabetes? Our guest, Dr. Niren Angle, chief of vascular and endovascular surgery at the University of California, San Diego, outlines the symptoms, diagnosis and treatment for peripheral artery disease. Join host Dr. Steven Edelman to learn more.
Guest: Susan Phillips, MD
Host: Steven Edelman, MD
The incidence of diabetes is increasing per year in the US and globally. The trend data suggests that obesity may be driving autoimmune beta cell failure. Some have questioned whether excess obesity or adiposity might be playing a role in this increased incidence of type 1 diabetes or whether healthcare professionals are not recognizing type 2 diabetes in youth. Join host Dr. Steven Edelman and his guest, pediatric endocrinologist and clinical researcher, Dr. Susan Phillips, as they discuss the challenges facing healthcare professionals in the diagnosis and treatment of diabetes in childhood.
Guest: Janis Roszler, CDE, RD, LD/N
Host: Steven Edelman, MD
A certified diabetes educator can help both physicians and patients when it comes to sexual dysfunction. Sexual dysfunction is experienced by over half of all women with diabetes, and approximately 32 percent of men with type 1 and 46 percent of men with type 2. So, it is critical to provide good communication. Our guest, certified diabetes educator and sex specialist Janis Roszler, outlines the benefits of good communication for healthcare professionals and their patients. Join host Dr. Steven Edelman to learn more.
Guest: James Wolosin, MD
Host: Steven Edelman, MD
Almost a third of all diabetics develop gastrointestinal complications specifically related to their diabetes. Host Dr. Steven Edelman is joined by his guest, gastroenterologist Dr. James Wolosin, senior staff physician at Sharp Healthcare San Diego, to discuss the treatment of gastroparesis, autonomic neuropathy and celiac disease.
Guest: Shazia Jamil, MD
Host: Steven Edelman, MD
Type 2 diabetes and obstructive sleep apnea have been shown to have a close relationship. Join host Dr. Steven Edelman and his guest, sleep specialist and pulmonologist Dr. Shazia Jamil, as they discuss the diagnosis and treatments of obstructive sleep apnea including continuous positive airway pressure (or CPAP) and surgery.
Guest: Chris Sadler, MA, PA-C, CDE
Host: Steven Edelman, MD
Technology continues to show great promise for people living with diabetes. One such technology is continuous glucose monitoring, a dynamic new technology with the potential to dramatically change the lives of type 1 diabetics and insulin-requiring type 2 diabetics. Join host Dr. Steven Edelman and his guest, certified diabetes educator and physician assistant Chris Sadler, as they discuss the benefits of continuous glucose monitoring.
Host: Steven Edelman, MD
Guest: Paul Tornambe, MD
Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. Join host Dr. Steven Edelman and his guest, ophthalmologist Dr. Paul Tornambe, an instructor in the departments of ophthalmology and family practice at the University of California, San Diego, as they discuss early diagnosis, tele-health and the exciting new VEGF inhibitors treatment of diabetic macular edema.
Guest: Ian Blumer, MD
Host: Steven Edelman, MD
Type 2 diabetes is a progressive disease and most patients will eventually need insulin to achieve euglycemia. Early and aggressive management to lower blood glucose reduces the risk of complications of the disease. It can be challenging for health care professionals to decide which treatment regimen is appropriate to manage a particular patient. Join host Dr. Steven Edelman and his guest, endocrinologist and medical advisor to the Charles H. Best Diabetes Centre in Ontario, Canada, Dr. Ian Blumer, as they discuss insulin initiation strategies.